355 results on '"Monteiro, Beatriz"'
Search Results
152. Efficacy and pharmacokinetics of bupivacaine with epinephrine or dexmedetomidine after intraperitoneal administration in cats undergoing ovariohysterectomy
- Author
-
Benito, Javier, Monteiro, Beatriz, Beaudry, Francis, and Paulo Steagall
- Subjects
Pain, Postoperative ,Epinephrine ,Ovariectomy ,Cats ,Animals ,Female ,Analgesics, Non-Narcotic ,Anesthetics, Local ,Hysterectomy ,Bupivacaine ,Dexmedetomidine ,Article - Abstract
The aim of this study was to determine the efficacy and pharmacokinetics of bupivacaine in combination with epinephrine or dexmedetomidine after intraperitoneal administration in cats undergoing ovariohysterectomy. Sixteen healthy adult cats (3.3 ± 0.6 kg) were included in a prospective, randomized, masked clinical trial after obtaining owners’ consent. Anesthetic protocol included buprenorphine-propofol-isoflurane. Meloxicam [0.2 mg/kg body weight (BW)] was administered subcutaneously before surgery. Cats were randomly divided into 2 groups to receive 1 of 2 treatments. Intraperitoneal bupivacaine 0.25% (2 mg/kg BW) was administered with epinephrine (BE group; 2 μg/kg BW) or dexmedetomidine (BD group; 1 μg/kg BW) before ovariohysterectomy (n = 8/group). A catheter was placed in the jugular vein for blood sampling. Blood samples were collected for up to 8 h after bupivacaine was administered. Plasma concentrations and pharmacokinetics of bupivacaine were determined using liquid chromatography tandem mass spectrometry (LC-MS/MS) and non-compartmental model, respectively. Pain was evaluated using the UNESP-Botucatu multidimensional composite pain scale (MCPS), the Glasgow composite feline pain scale (GPS), and a dynamic visual analog scale up to 8 h after extubation. Rescue analgesia was provided with buprenorphine if MCPS was ≥ 6. Repeated measures linear models were used for analysis of pain and sedation scores (P < 0.05). Maximum bupivacaine plasma concentrations (Cmax) for BE and BD were 1155 ± 168 ng/mL and 1678 ± 364 ng/mL (P = 0.29) at 67 ± 13 min (Tmax) and 123 ± 59 min (P = 0.17), respectively. Pharmacokinetic parameters and pain scores were not different between treatments (P > 0.05). One cat in the BE group received rescue analgesia (P = 0.30). Intraperitoneal bupivacaine with epinephrine or dexmedetomidine produced concentrations below toxic levels and similar analgesic effects. It is therefore safe to administer these drug combinations in cats undergoing ovariohysterectomy.
153. Additional file 1: of Safety and efficacy of reduced dosage ketoprofen with or without tramadol for long-term treatment of osteoarthritis in dogs: a randomized clinical trial
- Author
-
Monteiro, Beatriz, Lambert, Cedric, Bianchi, Elena, Genevois, Jean, Soldani, Giulio, and Troncy, Eric
- Subjects
3. Good health - Abstract
Standardized Veterinarian Arthritis Pain Scale (SVAPS). The questionnaire used by a blinded veterinarian to assess osteoarthritic pain in dogs is presenting five sections, respectively Global assessment, Lameness, Willingness to hold up contralateral (to the most affected) limb, Reaction to the palpation/ mobilization of the affected area, and Intensity/ nature of this reaction. (DOCX 20 kb)
154. Additional file 1: of Safety and efficacy of reduced dosage ketoprofen with or without tramadol for long-term treatment of osteoarthritis in dogs: a randomized clinical trial
- Author
-
Monteiro, Beatriz, Lambert, Cedric, Bianchi, Elena, Genevois, Jean, Soldani, Giulio, and Troncy, Eric
- Subjects
3. Good health - Abstract
Standardized Veterinarian Arthritis Pain Scale (SVAPS). The questionnaire used by a blinded veterinarian to assess osteoarthritic pain in dogs is presenting five sections, respectively Global assessment, Lameness, Willingness to hold up contralateral (to the most affected) limb, Reaction to the palpation/ mobilization of the affected area, and Intensity/ nature of this reaction. (DOCX 20 kb)
155. Pain Management in a Dog Undergoing Orthopedic Surgery.
- Author
-
Monteiro, Beatriz P. and Steagall, Paulo V.
- Subjects
PAIN management ,ORTHOPEDIC surgery - Published
- 2017
156. Reabilitação de uma lesão de mancha branca com a técnica ICON®: relato de caso clínico
- Author
-
Piacenza, Sophia Pierrine Baya and Monteiro, Beatriz
- Subjects
Treatment ,Tratamento ,Ciências Médicas::Medicina Clínica [Domínio/Área Científica] ,Diagnóstico ,White spot lesion ,Diagnosis ,Resina infiltrante ICON® ,Hipomineralização traumática ,Icon infiltrating resin ,Lesão de mancha branca ,Traumatic hypomineralization - Abstract
Submitted by Ana Moreira (anadsmoreira@ufp.pt) on 2021-10-26T08:35:50Z No. of bitstreams: 1 PPG_38380.pdf: 1312319 bytes, checksum: e25bc6a8a7a46113a5a41381a95588f1 (MD5) Approved for entry into archive by azevedo@ufp.pt (azevedo@ufp.pt) on 2021-10-26T14:06:49Z (GMT) No. of bitstreams: 1 PPG_38380.pdf: 1312319 bytes, checksum: e25bc6a8a7a46113a5a41381a95588f1 (MD5) Made available in DSpace on 2021-10-26T14:06:49Z (GMT). No. of bitstreams: 1 PPG_38380.pdf: 1312319 bytes, checksum: e25bc6a8a7a46113a5a41381a95588f1 (MD5) Previous issue date: 2021-07-08
- Published
- 2021
157. Abordagem terapêutica de desgastes erosivos: revisão narrativa
- Author
-
Lekhetari, Selssabil and Monteiro, Beatriz
- Subjects
Desgaste dentário ,Tratamento desgaste dentário erosivo ,Enamel ,Erosion ,Ciências Médicas::Medicina Clínica [Domínio/Área Científica] ,DVO alteration ,Erosão ,Tooth wear ,Esmalte ,Erosive dental wear rehabilitation ,Alteração DVO - Abstract
Submitted by Ana Moreira (anadsmoreira@ufp.pt) on 2021-10-20T16:31:43Z No. of bitstreams: 1 PPG_35129.pdf: 468211 bytes, checksum: 32599705596a04d174b29a3a3bb07991 (MD5) Approved for entry into archive by azevedo@ufp.pt (azevedo@ufp.pt) on 2021-10-21T09:00:18Z (GMT) No. of bitstreams: 1 PPG_35129.pdf: 468211 bytes, checksum: 32599705596a04d174b29a3a3bb07991 (MD5) Made available in DSpace on 2021-10-21T09:00:18Z (GMT). No. of bitstreams: 1 PPG_35129.pdf: 468211 bytes, checksum: 32599705596a04d174b29a3a3bb07991 (MD5) Previous issue date: 2021-07-02
- Published
- 2021
158. Abordagem clínica de lesões de hipomineralização molar-incisivo com aplicação da técnica ICON®: revisão narrativa
- Author
-
Lekhetari, Romaissa and Monteiro, Beatriz
- Subjects
Infiltração de resina ,Lesões de manchas brancas ,Ciências Médicas::Medicina Clínica [Domínio/Área Científica] ,Resina Icon® ,Hipomineralizaçao molar-incisivo ,Resin Icon® ,White spot lesions ,Molar-incisive hypomineralization ,Resin infiltration - Abstract
Submitted by Ana Moreira (anadsmoreira@ufp.pt) on 2021-10-20T15:51:29Z No. of bitstreams: 1 PPG_35127.pdf: 333919 bytes, checksum: eb23390850e488e4c50c971ae6bcb9e2 (MD5) Approved for entry into archive by azevedo@ufp.pt (azevedo@ufp.pt) on 2021-10-21T08:53:42Z (GMT) No. of bitstreams: 1 PPG_35127.pdf: 333919 bytes, checksum: eb23390850e488e4c50c971ae6bcb9e2 (MD5) Made available in DSpace on 2021-10-21T08:53:42Z (GMT). No. of bitstreams: 1 PPG_35127.pdf: 333919 bytes, checksum: eb23390850e488e4c50c971ae6bcb9e2 (MD5) Previous issue date: 2021-07-02
- Published
- 2021
159. Técnica de customização de sistemas retentivas intra-radiculares: revisão narrativa
- Author
-
Khadivi, Khashayar and Monteiro, Beatriz
- Subjects
Customized post ,Espigão customizado ,Post ,Espigão de fibra de vidro ,Endodontic ,Ciências Médicas::Medicina Clínica [Domínio/Área Científica] ,Fiber post ,Endodontia ,Espigão ,Núcleo ,Core - Abstract
Submitted by Ana Moreira (anadsmoreira@ufp.pt) on 2021-10-20T16:44:36Z No. of bitstreams: 1 PPG_38326.pdf: 298098 bytes, checksum: 8f737d00be8e2f8bfb8a08af73158e21 (MD5) Approved for entry into archive by azevedo@ufp.pt (azevedo@ufp.pt) on 2021-10-21T09:02:27Z (GMT) No. of bitstreams: 1 PPG_38326.pdf: 298098 bytes, checksum: 8f737d00be8e2f8bfb8a08af73158e21 (MD5) Made available in DSpace on 2021-10-21T09:02:27Z (GMT). No. of bitstreams: 1 PPG_38326.pdf: 298098 bytes, checksum: 8f737d00be8e2f8bfb8a08af73158e21 (MD5) Previous issue date: 2021-06-30
- Published
- 2021
160. Perspectives on schizophrenia: from psychiatric medicine to psychoanalytical therapy
- Author
-
Nogueira, Roseli de Cassia [UNIFESP] and Monteiro, Beatriz de Oliveira [UNIFESP]
- Subjects
Esquizofrenia ,Terapia psicanalítica - Abstract
O presente trabalho teve como objetivo aprofundar conhecimentos sobre a esquizofrenia e as diferentes condutas e tratamentos propostos na clínica psiquiátrica e no set psicanalítico. A necessidade de evidências sobre estas duas abordagens levou ao desenvolvimento deste estudo, tendo como objetivo a comparação de alguns aspectos das duas condutas, por meio de uma revisão da literatura. Como estratégia de trabalho, foi desenvolvido um estudo comparativo entre a psicanálise e a medicina psiquiátrica em relação aos tratamentos oferecidos para essa condição, que são tratamentos com diretrizes e motivações diferentes. De um lado, a psicanálise se preocupa com a “psique” investigando o sujeito e o aparelho psíquico, e de outro a medicina psiquiátrica, que lida com a questão orgânica e o tratamento imediato para promover o alívio e a supressão dos sintomas. O paciente esquizofrênico, no entanto, precisa de ambos, do alívio dos sintomas e do acolhimento e escuta psicanalítica. Estratégias combinadas seriam mais eficientes?
- Published
- 2021
161. Efeito do transplante hipocampal de célula tronco neural e mesenquimal e do exercício físico resistido em camundongos transgênicos para a doença de Alzheimer
- Author
-
Campos, Henrique Correia [UNIFESP], Monteiro, Beatriz de Oliveira [UNIFESP], and Ribeiro, Deidiane Elisa
- Subjects
Transplante de células tronco mesenquimais e neurais ,Hipocampo ,Exercício resistido ,Placas β-amiloide ,Doença de Alzheimer - Abstract
Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES) Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP) Objetivo: Este trabalho visa investigar os efeitos de dois tipos de intervenções: o transplante de Células Tronco Mesenquimais (CTM) e Células Tronco Neurais (CTN) e a aplicação de protocolos de exercício resistido diário (ERd) e intermitente (ERi), na recuperação da condição neuropatológica em animais duplo-transgênicos para a Doença de Alzheimer (DA) APPswe/PS1ΔE9 (APP/PS1), avaliando o comportamento motor, memória de reconhecimento, memória de curto e longo prazo por testes comportamentais, e análise histológica por imuno-histoquímica. Métodos: Abaixo estão descritas metodologias utilizadas nos dois estudos, divergindo apenas nas metodologias sobre transplante, exercício resistido e quantificação de corticosterona. Camundongos machos adultos APP/PS1 e selvagens (CTRL) foram divididos nos seguintes grupos: CTRL, APP/PS1, APP/PS1+CTM, APP/PS1+CTN, APP/PS1+ERd e APP/PS1+ERi (n = 15 para cada grupo). CTM de medula óssea de camundongos adultos green fluorescent protein (eGFP / C57) e CTN do telencéfalo de embriões eGFP / C57 foram transplantadas no hipocampo dos grupos APP/PS1+CTM e APP/PS1+CTN. O protocolo de ERd foi aplicado no grupos APP/PS1+ERd e o protocolo de ERi no grupo APP/PS1+ERi. Após cinco semanas do transplante ou protocolos de exercício, os animais foram submetidos aos testes comportamentais de campo aberto, reconhecimento de objetos e esquiva passiva para avaliação motora, memória de curto e longo prazo. Após os testes, os cérebros foram removidos para realização de imuno-histoquímica, para análise de placas βA com anticorpo anti-6-E10, neurogênese com anti-DCX e células microgliais com anti-Iba-1. O sangue foi obtido para quantificação de corticosterona plasmática de animais CTRL, APP/PS1, APP/PS1+ERd e APP/PS1+ERi. A análise estatística foi conduzida com o auxílio dos programas StrataQuest (TissueGnostics GmbH) e Graphpad Prism versão 8.0. Resultados: Os transplantes de CTM e CTN reduziram o número de placas βA no hipocampo de camundongos APP/PS1. Transplante de CTN aumentou a neurogênese e o número de células microgliais no hipocampo de camundongos APP/PS1, além de reverter as alterações na locomoção central e periférica apresentadas por esses animais no teste do campo aberto. Os programas de ERd e ERi causaram redução nos níveis de corticosterona no plasma de animas APP/PS1, reverteram as alterações na locomoção central e periférica apresentadas no teste do campo aberto, além de diminuir o número de placas βA no hipocampo desses animais, porém não houve efeito do programa de ERd e ERi na neurogênese. O programa de ERi aumentou a quantidade, e ERd e ERi aumentaram a área de micróglia presentes no hipocampo de animais APP/PS1. Os testes comportamentais para avaliação da memória mostraram que camundongos APP/PS1 não apresentam prejuízo na memória de reconhecimento e memórias de curto e longo prazo. Conclusão: O transplante de CTM e CTN assim como os programas de ERd e ERi obtiveram efeito na diminuição de placas βA, aumento de neurogênese, células microgliais e reversão da hiperlocomoção em animais APP/PS1. Além de o programa de ERd e ERi reverterem os níveis de corticosterona plasmático nesses mesmos animais, mostrando efeitos positivos dessas intervenções no tratamento da DA. 88882.330549/2019-01
- Published
- 2021
162. Tratamento de lesões de fluorose com aplicação da técnica ICON® - revisão narrativa
- Author
-
Bastos, Francisco José Cerqueira de Lemos and Monteiro, Beatriz
- Subjects
Fluorosis stains ,Fluorosis ,Ciências Médicas::Medicina Clínica [Domínio/Área Científica] ,Fluorose ,Resina infiltrativa ,Manchas ,Infiltrative resin ,ICON® ,Manchas de fluorose ,Stains - Abstract
Submitted by azevedo@ufp.pt (azevedo@ufp.pt) on 2021-03-02T00:47:50Z No. of bitstreams: 1 PPG_33757.pdf: 445909 bytes, checksum: 6791ba681391be27e3d91b1a527f0d8d (MD5) Approved for entry into archive by azevedo@ufp.pt (azevedo@ufp.pt) on 2021-03-15T11:44:30Z (GMT) No. of bitstreams: 1 PPG_33757.pdf: 445909 bytes, checksum: 6791ba681391be27e3d91b1a527f0d8d (MD5) Made available in DSpace on 2021-03-15T11:44:31Z (GMT). No. of bitstreams: 1 PPG_33757.pdf: 445909 bytes, checksum: 6791ba681391be27e3d91b1a527f0d8d (MD5) Previous issue date: 2020-11-20
- Published
- 2020
163. Gender differences in evidence-based pharmacological therapy for patients with stable coronary heart disease
- Author
-
Lahoz, Carlos, Mantilla, Teresa, Taboada, Manuel, Soler, Begoña, Tranche, Salvador, López-Rodriguez, Isidro, Monteiro, Beatriz, Martin-Jadraque, Raquel, Sanchez-Zamorano, Miguel A., and Mostaza, Jose M.
- Subjects
- *
SEX factors in disease , *CORONARY disease , *HEART disease related mortality , *EVIDENCE-based medicine , *CROSS-sectional method , *HEART disease risk factors , *HOSPITAL care , *PATIENTS - Abstract
Abstract: Background: Women have a higher morbidity and mortality than men after an acute coronary event. We analyzed the prescription rates of evidence-based pharmacological therapies for patients with stable coronary heart disease and whether there were any differences with respect to gender. Design: This cross-sectional study evaluated 8817 patients, 26.3% women, receiving attention from 1799 family doctors in primary care centers (PCC) throughout Spain, and who had had a coronary event requiring hospitalization in the previous 6 months to 10 years. Results: Mean age was 65.4 years and a mean time-lapse since hospitalization of 37.4 months. In the overall population, prescription medications were: antiplatelet drugs in 80.5% of patients, 79% statins, 66% blockers of the angiotensin–renin system (BARS) and 47% beta-blockers. Males received less cardiovascular disease medications than females (4.3±1.5 versus 4.6±1.6, respectively; p <0.001), but when adjusted for risk factors the significance was lost (p =0.231). Following adjustment for risk factors and for co-morbidities, the use of diuretics was significantly higher in women while beta-blockers and statins were higher in men. The triple combination of antithrombotics, beta-blockers and statins was used in 41.4% (43.8% males versus 34.6% females; p <0.001) while 24.3% used this triple combination plus a BARS; without significant difference between the genders. Conclusions: An important percentage of patients with stable coronary disease, particularly women, attended-to in primary care do not receive medications that have been shown to decrease the morbido-mortality of cardiovascular disease. [Copyright &y& Elsevier]
- Published
- 2009
- Full Text
- View/download PDF
164. O uso do diamino fluoreto de prata: revisão narrativa atual
- Author
-
Rodrigues, Margarida Sofia Barbosa and Monteiro, Beatriz
- Subjects
Silver Diamine Flouride ,Ciências Médicas::Medicina Clínica [Domínio/Área Científica] ,Diagnosis ,Treatment and Indications - Abstract
Submitted by Ana Moreira (anadsmoreira@ufp.pt) on 2020-07-07T11:51:52Z No. of bitstreams: 1 PPG_26551.pdf: 291379 bytes, checksum: a2a5a8f6c986d7ff34e12bdd6f302b33 (MD5) Approved for entry into archive by azevedo@ufp.pt (azevedo@ufp.pt) on 2020-07-14T11:56:32Z (GMT) No. of bitstreams: 1 PPG_26551.pdf: 291379 bytes, checksum: a2a5a8f6c986d7ff34e12bdd6f302b33 (MD5) Made available in DSpace on 2020-07-14T11:56:32Z (GMT). No. of bitstreams: 1 PPG_26551.pdf: 291379 bytes, checksum: a2a5a8f6c986d7ff34e12bdd6f302b33 (MD5) Previous issue date: 2019-11-27
- Published
- 2019
165. Amelogénese imperfeita: revisão narrativa da literatura
- Author
-
Ponthieu, Victor Robert Raymond and Monteiro, Beatriz
- Subjects
Treatment ,Characteristics ,Amelogenesis Imperfecta ,Enamel ,Ciências Médicas::Medicina Clínica [Domínio/Área Científica] ,Diagnostic - Abstract
Submitted by Ana Moreira (anadsmoreira@ufp.pt) on 2020-07-27T10:40:58Z No. of bitstreams: 1 PPG_35596.pdf: 287874 bytes, checksum: 3fdbc07086c64066be4f147e1b9739dc (MD5) Approved for entry into archive by azevedo@ufp.pt (azevedo@ufp.pt) on 2020-08-04T15:49:16Z (GMT) No. of bitstreams: 1 PPG_35596.pdf: 287874 bytes, checksum: 3fdbc07086c64066be4f147e1b9739dc (MD5) Made available in DSpace on 2020-08-04T15:49:16Z (GMT). No. of bitstreams: 1 PPG_35596.pdf: 287874 bytes, checksum: 3fdbc07086c64066be4f147e1b9739dc (MD5) Previous issue date: 2019-10-24
- Published
- 2019
166. Eliminação de manchas brancas do esmalte com micro infiltração da resina Icon®
- Author
-
Dorban, Ibrahim and Monteiro, Beatriz
- Subjects
Microinfiltration of resin ,Fluorosis ,WSL ,Microabarasion ,Ciências Médicas::Medicina Clínica [Domínio/Área Científica] ,White spot lesion ,Icon ,MIH ,Traumatic hypomineralization - Abstract
Submitted by azevedo@ufp.pt (azevedo@ufp.pt) on 2019-12-27T10:39:32Z No. of bitstreams: 1 PPG_29009.pdf: 568204 bytes, checksum: 3cc4e279848a22b3ebf5fd974a95eea5 (MD5) Approved for entry into archive by halves@ufp.pt (halves@ufp.pt) on 2019-12-27T11:22:28Z (GMT) No. of bitstreams: 1 PPG_29009.pdf: 568204 bytes, checksum: 3cc4e279848a22b3ebf5fd974a95eea5 (MD5) Made available in DSpace on 2019-12-27T11:22:28Z (GMT). No. of bitstreams: 1 PPG_29009.pdf: 568204 bytes, checksum: 3cc4e279848a22b3ebf5fd974a95eea5 (MD5) Previous issue date: 2019-07-05
- Published
- 2019
167. Facetas cerâmicas sem preparo: uma revisão atual
- Author
-
Mbissi, Malvina Maeliss and Monteiro, Beatriz
- Subjects
Cerâmica ,Ciências Médicas::Medicina Clínica [Domínio/Área Científica] ,Estética ,Facetas peliculares ,Ceramic veneers ,Lentes de contacto dentárias ,Aesthetics ,Ceramics veneers ,No prep veneers ,Facetas sem preparo ,Contact lenses ,Porcelain laminate veneers - Abstract
Submitted by azevedo@ufp.pt (azevedo@ufp.pt) on 2019-05-22T11:27:38Z No. of bitstreams: 1 PPG_31079.pdf: 519833 bytes, checksum: 0330f23a2247ed21fb436c8e7d2a217e (MD5) Approved for entry into archive by halves@ufp.pt (halves@ufp.pt) on 2019-05-22T11:39:37Z (GMT) No. of bitstreams: 1 PPG_31079.pdf: 519833 bytes, checksum: 0330f23a2247ed21fb436c8e7d2a217e (MD5) Made available in DSpace on 2019-05-22T11:39:38Z (GMT). No. of bitstreams: 1 PPG_31079.pdf: 519833 bytes, checksum: 0330f23a2247ed21fb436c8e7d2a217e (MD5) Previous issue date: 2018-11-28
- Published
- 2018
168. Alterações comportamentais induzidas pela administração intrahipocampal de pilocarpina: relevância para o estudo das comorbidades em modelos animais de epilepsia do lobo temporal
- Author
-
Araújo, Caroline Pereira de, Cammarota, Martin Pablo, Monteiro, Beatriz de Oliveira, and Queiroz, Cláudio Marcos Teixeira de
- Subjects
Pilocarpina ,OUTROS::CIENCIAS [CNPQ] ,Comorbidade ,Hipocampo ,Memória ,Ácido caínico ,Epilepsia do Lobo Temporal - Abstract
A epilepsia do lobo temporal (ELT) é a forma mais comum de epilepsia focal. Modelos animais reproduzem a condição humana por meio da administração sistêmica de pilocarpina (PILO) ou ácido caínico (KA). Experimentalmente, esses modelos envolvem um insulto inicial (status epilepticus - SE), que resulta em morte neuronal, reorganização estrutural e crises espontâneas e recorrentes, além de prejuízos de performance em diversas tarefas comportamentais. As estruturas neurais associadas aos prejuízos cognitivos desses modelos não são inteiramente conhecidas, e provavelmente a existência de múltiplos focos epilépticos contribui para a variabilidade experimental frequentemente observada. Como forma de reduzir o aparecimento de múltiplos focos epilépticos, propomos um protocolo no qual os agentes convulsivantes são administrados localmente (i.e., diretamente em um hipocampo ao invés da via intraperitoneal, i.p.). Apesar de estudos com KA em camundongos já terem sido realizados, nenhum trabalho avaliou os efeitos da administração intra-hipocampal (ihpc) de PILO em camundongos. Assim, neste trabalho é apresentado os efeitos comportamentais agudos e crônicos da aplicação ihpc de 4 doses de PILO (70, 245, 400 e 700 µg, diluídas em 1 µL) em camundongo anestesiados com isoflurano. Animais tratados com KA (20 mM, 50 nL) e cloreto de sódio (0,9%) foram usadas como tratamentos controle. Observamos uma correlação entre a severidade do SE (quantificado agudamente por escalas e de maneira indireta, por meio da evolução ponderal) e a concentração de PILO administrada. Ao contrário do observado quando dada sistemicamente, o tratamento ihpc (n = 63) não resulta em crises tônicas, contribuindo para a baixa mortalidade do modelo (ihpc: 4/62; ip: 10/11). No período crônico (1 mês após o SE), camundongos tratados com altas doses de PILO apresentaram crises espontâneas, assim como os animais tratados com KA. Testes comportamentais revelaram que animais epilépticos (independente do agente convulsivante) apresentam maior ambulação estereotipada (campo aberto) que animais do grupo controle. Em testes de memória dependentes do hipocampo, o tratamento com PILO, especialmente em altas doses, prejudicou o desempenho na tarefa de reconhecimento de objetos, mas não no labirinto de Barnes. Animais do grupo KA apresentaram desempenho inferior em todos os testes, quando comparado ao grupo PILO (alta dose). Em conjunto, nossos resultados demonstram que a administração ihpc de PILO em camundongos resulta em crises espontâneas e recorrentes, além de prejuízos cognitivos moderados (compatíveis com as comorbidades observadas em seres humanos com ELT), além de baixa mortalidade. Acreditamos que o presente modelo apresenta validade de face para ELT, podendo servir como alternativa aos modelos do KA (cujo custo é alto) e à via de administração (cuja mortalidade é alta quando a PILO é administrada sistemicamente). Temporal Lobe Epilepsy (TLE) is the most common form of focal epilepsy. The human condition can be modeled in animals by the systemic administration of pilocarpine (PILO) or kainic acid (KA). The experimental approach involves an initial insult (status epilepticus - SE) resulting in widespread cell death, structural reorganization, chronic spontaneous seizures and, impaired performance in memory tasks and anhedonia. The identification of the anatomical substrates related to the cognitive impairments in those models is not entirely known, since systemic administration may lead to multiple epileptic foci. To minimize the impact of spatially distributed, numerous epileptic foci, on cognitive performance, we present a protocol in which the convulsant agent is administered directly in the target structure of interest (i.e., straight into the hippocampus). This approach has been used for KA in mice, but no systematic study has evaluated the effects of intrahippocampal administration of PILO. Here, we described the acute and chronic behavioral effects of the intrahippocampal administration of PILO (4 doses: 70, 245, 400 e 700 µg, in 1 µL) in mice during isoflurane anesthesia. KA (20 mM, 50 nL) and saline (0.9 %) were used as positive and negative controls, respectively. The results show a correlation between the severity of the SE and the dose of PILO given (measured acutely by behavioral scores and indirectly through the evolution of weight). Interestingly, intrahippocampal PILO injection (N=62) did not elicit tonic seizures, as commonly observed after systemic administration which contributed to the low mortality rate of the model (4 out of 63 and 10 out of 11, respectively). In the chronic phase (1 month after SE), mice treated with high doses of PILO and KA presented spontaneous seizures. Behavioral tests revealed that epileptic animals (independent of the convulsive drug used) present higher stereotyped ambulation (in the open-field) than animals from the control group. In hippocampal-dependent memory tests, PILO treatment, especially at high doses, impaired performance in the object recognition task, but not in the Barnes maze. Animals from the KA group presented impaired performance in all memory tests compared with the PILO group (high dose). Taken together, our results demonstrate that ihpc administration of PILO in mice results in spontaneous and recurrent seizures, as well as moderate cognitive impairment (compatible with comorbidities observed in humans with TLE), and low mortality rate. We believe that the present model has face validity for human TLE, and may serve as an alternative to KA models (which are expensive) and to the route of administration (high mortality when PILO is administered systemically).
- Published
- 2018
169. Branqueamento dentário interno: uma revisão bibliográfica
- Author
-
Marques, Filipa Dias and Monteiro, Beatriz
- Subjects
Whitening Agents ,Tooth Whitening ,Ciências Médicas::Medicina Clínica [Domínio/Área Científica] ,Branqueamento Interno ,Técnicas de Branqueamento ,Internal Bleaching ,Agentes Branqueadores ,Bleaching Techniques ,Branqueamento Dentário - Abstract
Submitted by halves@ufp.pt (halves@ufp.pt) on 2019-02-06T12:14:00Z No. of bitstreams: 1 PPG_29687.pdf: 642507 bytes, checksum: ddf419a18640558d320448503e278c20 (MD5) Approved for entry into archive by halves@ufp.pt (halves@ufp.pt) on 2019-02-06T12:16:22Z (GMT) No. of bitstreams: 1 PPG_29687.pdf: 642507 bytes, checksum: ddf419a18640558d320448503e278c20 (MD5) Made available in DSpace on 2019-02-06T12:16:22Z (GMT). No. of bitstreams: 1 PPG_29687.pdf: 642507 bytes, checksum: ddf419a18640558d320448503e278c20 (MD5) Previous issue date: 2018-07-23
- Published
- 2018
170. Diastemas interincisivos superiores: revisão da literatura
- Author
-
Ramos, Bruno Abril and Monteiro, Beatriz
- Subjects
Dentística ,Frenectomy ,Etiology ,Ciências Médicas::Medicina Clínica [Domínio/Área Científica] ,Diastema ,Etiologia ,Estética ,Dentistry ,Central incisor ,Aesthetics ,Incisivo central ,Frenectomia - Abstract
Submitted by azevedo@ufp.pt (azevedo@ufp.pt) on 2019-01-15T11:37:25Z No. of bitstreams: 1 PPG_26441.pdf: 547407 bytes, checksum: e321e3a0264e5cb08d070f9c3754c7cd (MD5) Approved for entry into archive by halves@ufp.pt (halves@ufp.pt) on 2019-01-15T11:38:00Z (GMT) No. of bitstreams: 1 PPG_26441.pdf: 547407 bytes, checksum: e321e3a0264e5cb08d070f9c3754c7cd (MD5) Made available in DSpace on 2019-01-15T11:38:01Z (GMT). No. of bitstreams: 1 PPG_26441.pdf: 547407 bytes, checksum: e321e3a0264e5cb08d070f9c3754c7cd (MD5) Previous issue date: 2018-07-19
- Published
- 2018
171. Hipersensibilidade dentinária: diferentes abordagens terapêuticas
- Author
-
Lekhetari, Imane and Monteiro, Beatriz
- Subjects
Agentes dessensibilizantes ,Etiology of dentin pain ,Dentina sensível ,Ciências Médicas::Medicina Clínica [Domínio/Área Científica] ,Diagnóstico ,Dentin sensitive ,Diagnosis ,Etiologia da dor dentinária ,Prevalence ,Prevalência ,Hipersensibilidade dentinária ,Dentin hypersensitivity ,Desensitizing agent - Abstract
Submitted by halves@ufp.pt (halves@ufp.pt) on 2018-12-28T09:42:57Z No. of bitstreams: 1 PPG_29941.pdf: 890358 bytes, checksum: 7c4fd6873aee465b574e8388ce320383 (MD5) Approved for entry into archive by halves@ufp.pt (halves@ufp.pt) on 2018-12-28T10:29:57Z (GMT) No. of bitstreams: 1 PPG_29941.pdf: 890358 bytes, checksum: 7c4fd6873aee465b574e8388ce320383 (MD5) Made available in DSpace on 2018-12-28T10:29:57Z (GMT). No. of bitstreams: 1 PPG_29941.pdf: 890358 bytes, checksum: 7c4fd6873aee465b574e8388ce320383 (MD5) Previous issue date: 2018-06-20
- Published
- 2018
172. Uso de transplante de astrócitos na redução da epilepsia experimental
- Author
-
Farias, Kelly Soares, Sequerra, Eduardo Bouth, Pereira, Rodrigo Neves Romcy, Monteiro, Beatriz de Oliveira, Castro, Olagide Wagner de, and Queiroz, Cláudio Marcos Teixeira de
- Subjects
Crises espontâneas e recorrentes ,Astrócitos ,Epilepsia do lobo temporal ,Terapia celular ,Espículas interictais ,OUTROS::CIENCIAS: NEUROCIÊNCIAS [CNPQ] - Abstract
Os astrócitos, células especializadas da glia, estão envolvidos na homeostase extracelular por tamponar íons de potássio (K+), metabolizar neurotransmissores, controlar o disparo e a sincronização neuronal e contribuir para a formação da barreira hematoencefálica. Em condições patológicas, os astrócitos podem alterar a sua morfologia (hipertrofia dos seus processos celulares) e bioquímica (aumento da expressão da proteína ácida fibrilar glial, GFAP), sendo conhecidos por astrócitos reativos (a.k.a., gliose reativa). Apesar de serem frequentemente observados em regiões cerebrais associadas à geração e propagação de crises epilépticas, a participação dos astrócitos reativos na sincronização anormal é pouco conhecida. Enquanto os astrócitos modificam o metabolismo do potássio e do glutamato, a sua reativação, por períodos prolongados, pode levar à disfunção da atividade neuronal. A epilepsia do lobo temporal (ELT), uma das formas mais comuns de epilepsia e frequentemente associada à refratariedade ao tratamento farmacológico, é caracterizada por morte neuronal em regiões temporais (esclerose do hipocampo), reorganização sináptica (brotamento aberrante de fibras musgosas) e gliose reativa. Nessa tese testamos a hipótese de que o transplante de astrócitos imaturos no hipocampo de animais cronicamente epiléticos reduzirá a atividade epileptiforme, incluindo a ocorrência de crises espontâneas eletrográficas e comportamentais. Para isso, os animais foram feitos epilépticos pela injeção sistêmica da pilocarpina (que induziu o estado epiléptico, SE) e foram transplantados unilateralmente no hilo do giro denteado (GD) com astrócitos que expressavam a proteína fluorescente verde (GFP+) 30 dias após o SE. A alocação dos animais epilépticos nos grupos controle (SE-controle) e experimental (SE-astro GD) foi feita de acordo com a severidade comportamental do SE. Atividades epileptiformes espontâneas (espículas interictais, oscilações de alta frequência e crises recorrentes) foram registradas em ambos os hipocampos (tratado e não tratado) usando eletrodos cronicamente implantados. A sobrevivência dos astrócitos foi de 1 %. Astrócitos GFP+ foram encontrados em diversas sub-regiões hipocampais por até sete meses após o transplante, sendo que algumas células migraram aproximadamente até 1500 µm no polo anteroposterior. Essas células foram localizadas principalmente no hilo, na camada granular do giro dentado e na camada molecular do hipocampo, e em alguns animais, no córtex, tálamo e fímbria. Células ou grupos de tecidos indicativos de tumor não foram identificados. A atividade epileptiforme eletrográfica foi registrada em 80% dos animais controle (SE-controle, N = 8/10), em 80% dos animais experimentais com astrócitos GFP+ localizados no córtex (SE-Astro Córtex, N = 4/5) e em 60% dos animais com astrócitos GFP+ no hipocampo (SE-Astro GD, N=2/5). A frequência de crises espontâneas foi variável entre os animais (21 vs 12 vs 1 crises espontâneas registradas nos grupos SE-control, SEAstro Córtex e SE- Astro GD, respectivamente) e não houve diferença na frequência de crises entre os grupos (crises/hora: 0,05 ± 0,01 vs 0,03 ± 0,003 vs 0,02, para SE-controle e SE-Astro Córtex e SE-Astro GD, respectivamente). O transplante dos astrócitos não alterou a duração das crises (67,5 ± 3,6 s vs 74,2 ± 3,9 s vs 65,3, para SE-controle e SE-Astro Córtex e SE-Astro GD, respectivamente). Além disso, não observamos diferenças quanto à morfologia, periodicidade ou frequência das espículas interictais do hipocampo entre os grupos experimentais e/ou entre os hemisférios tratados. Interessantemente, o transplante de astrócitos reduziu significativamente a severidade das crises comportamentais nos animais que receberam astrócitos no córtex (Escala livre: 5,0 ± 0,6 vs 4,0 ± 0,4, SE-controle e SE-Astro Córtex, respectivamente, p=0,02, teste de MannWhitney). O grupo SE-Astro GD apresentou apenas uma crise epiléptica e, portanto, não candidato a estatística. Nossos resultados enfatizam o uso da terapia celular para o tratamento das epilepsias e reforçam a importância do sítio do transplante para a redução da atividade epileptiforme. Astrocytes are specialized glial cells involved in the extracellular homeostasis by buffering potassium cation (K+) concentration, metabolizing neurotransmitters, controlling neuronal firing and synchronization and contributing to the blood-brain barrier. Under pathological conditions, astrocytes may change their morphology in order to compensate abnormal function, being referred to as activated astrocytes (reactive gliosis). This phenomenon is commonly observed in brain regions associated with seizure generation and spread, although its role in abnormal synchronization is unknown. While astrocytes can enhance potassium and glutamate-related metabolism, sustained long-term reactivation can lead to neuronal dysfunction. Temporal lobe epilepsy (TLE) is the most common form of epilepsy and is usually associated to refractoriness. TLE is characterized by extensive cell death (hippocampal sclerosis), synaptic reorganization (mossy fiber sprouting) and reactive gliosis. Here, we hypothesize that transplantation of immature astrocytes in chronically epileptic hippocampus would reduce epileptiform activity, including the occurrence of electrographic and behavioral seizures. To test this hypothesis, animals made epileptic by the systemic injection of pilocarpine (which induced status epilepticus, SE) were unilaterally transplanted with green fluorescent protein-positive (GFP) astrocytes into the hippocampus 30 days after the SE. Group assignment (SE-Saline e SE-Astro GD) was made according to SE behavioral severity and spontaneous epileptiform activities (interictal spikes, high-frequency oscillations, seizures) were recorded in both (treated and untreated) hippocampi using chronically implanted multi-electrodes. Astrocytes had migrated approximately 1500µm injection site, and survival rate was 1%. Astrocytes were found in the host hippocampus seven months after transplantation and were mainly localized at the hilus, at the granular layer of the dentate gyrus, at molecular layer of hippocampus. Cells or tissue clusters indicative of tumor were not identified. In a second group, astrocytes were found in the cortex and constituted the SE-Astro Cortex group. No difference was found in epileptiform activity recorded between groups. Epileptiform electrographic activity was recorded in 80% of control animals (SE-Saline, N= 8/10, in 80% of SE-Astro Cortex group (SE-Astro Córtex, N=4/5) and in 60% of animals that received astrocytes into the hippocampus (SE-Astro GD, N=2/5). Spontaneous seizure occurrence was variable between animals (21 vs 12 vs 1 recorded seizures in SE-Saline and SE-Astro Cortex and SE-Astro GD groups, respectively), however, no difference was observed in seizure frequency between groups (seizures/hour: 0.05±0.01 vs 0.03±0.003 vs 0.02, SE-Saline, SE-Astro Cortex and SE-Astro GD, respectively). Astrocytes grafting did not change seizure duration (67.5 ± 3.6 s vs 74.2 ± 3.9 s vs 65.3 s for SE-Saline, SE-Astro Cortex and SE-Astro GD groups, respectively). Also, we did not observe any difference in the morphology, periodicity or frequency of hippocampal interictal spikes between experimental groups and/or treated hemisphere. Additionally, however, the animals of SE-Astro Cortex group showed reduced behavioral seizure severity (scores: 5 ± 0.1 vs 4 ± 0.4; for SE-Saline and SE-Astro Cortex, respectively; p =0.02, Mann-Whitney test). SE-Astro GD group animals showed only one spontaneous seizure, and therefore not a candidate for statistics. Even thought the small sample size, our results present the cell therapy relevance for the treatment of epilepsies and reinforce importance of transplantation site for epileptiform activity reduction.
- Published
- 2018
173. Encerramento de diastemas em dentes anteriores: opções terapêuticas
- Author
-
Silveira, Myllena Goulart and Monteiro, Beatriz
- Subjects
Resina compostas ,Crowns ,Ciências Médicas::Medicina Clínica [Domínio/Área Científica] ,Diastema ,Diastemas ,Tratamento de diastemas ,Restorations ,Tratamento ortodôntico ,Porcelain veneers ,Coroas totais ,Diastema closure ,Composite resin ,Restaurações ,Encerramento de diastema ,Orthodontic treatment ,Diastema treatment ,Facetas de cerâmica - Abstract
Submitted by azevedo@ufp.pt (azevedo@ufp.pt) on 2018-03-15T12:19:34Z No. of bitstreams: 1 PPG_35246.pdf: 678276 bytes, checksum: c99d3c94ab74b0b9270922d592ac5029 (MD5) Approved for entry into archive by halves@ufp.pt (halves@ufp.pt) on 2018-03-16T09:46:38Z (GMT) No. of bitstreams: 1 PPG_35246.pdf: 678276 bytes, checksum: c99d3c94ab74b0b9270922d592ac5029 (MD5) Made available in DSpace on 2018-03-16T09:46:38Z (GMT). No. of bitstreams: 1 PPG_35246.pdf: 678276 bytes, checksum: c99d3c94ab74b0b9270922d592ac5029 (MD5) Previous issue date: 2017-12-15
- Published
- 2017
174. Branqueamento interno
- Author
-
Martins, Noémia Cláudia Ribeiro and Monteiro, Beatriz
- Subjects
Bleaching Agents ,Branqueamento intracoronal ,Ciências Médicas::Medicina Clínica [Domínio/Área Científica] ,Non-vital bleaching ,Bleaching Effect ,Branqueamento dentes não vitais ,Intracoronal Bleaching ,Agentes branqueadores ,Branqueamento interno dentário ,Internal bleaching tooth - Abstract
Submitted by azevedo@ufp.pt (azevedo@ufp.pt) on 2018-03-15T17:29:28Z No. of bitstreams: 1 PPG_21664.pdf: 691085 bytes, checksum: 7416694d6332c724bfb2d8970e76356b (MD5) Approved for entry into archive by halves@ufp.pt (halves@ufp.pt) on 2018-03-16T09:49:58Z (GMT) No. of bitstreams: 1 PPG_21664.pdf: 691085 bytes, checksum: 7416694d6332c724bfb2d8970e76356b (MD5) Made available in DSpace on 2018-03-16T09:49:58Z (GMT). No. of bitstreams: 1 PPG_21664.pdf: 691085 bytes, checksum: 7416694d6332c724bfb2d8970e76356b (MD5) Previous issue date: 2017-11-24
- Published
- 2017
175. Branqueamento Interno: uma revisão bibliográfica
- Author
-
Boucinha, Manuel Luís Cardoso and Monteiro, Beatriz
- Subjects
Whitening Agents ,Tooth Whitening ,Ciências Médicas::Medicina Clínica [Domínio/Área Científica] ,Branqueamento Interno ,Técnicas de Branqueamento ,Internal Bleaching ,Agentes Branqueadores ,Bleaching Techniques ,Branqueamento Dentário - Abstract
Submitted by azevedo@ufp.pt (azevedo@ufp.pt) on 2018-02-12T16:30:43Z No. of bitstreams: 1 PPG_27496.pdf: 591624 bytes, checksum: fc1ec85b3a315dc05655355cc80588d1 (MD5) Approved for entry into archive by halves@ufp.pt (halves@ufp.pt) on 2018-02-14T08:20:01Z (GMT) No. of bitstreams: 1 PPG_27496.pdf: 591624 bytes, checksum: fc1ec85b3a315dc05655355cc80588d1 (MD5) Made available in DSpace on 2018-02-14T08:20:02Z (GMT). No. of bitstreams: 1 PPG_27496.pdf: 591624 bytes, checksum: fc1ec85b3a315dc05655355cc80588d1 (MD5) Previous issue date: 2017-07-26
- Published
- 2017
176. Hipersensibilidade dentinária: uma abordagem contemporânea
- Author
-
Ortolani, Alexandre Tassinari and Monteiro, Beatriz
- Subjects
Agentes dessensibilizantes dentinários ,Treatment ,Tratamento ,Dentin sensitivity ,Dentina sensível ,Ciências Médicas::Medicina Clínica [Domínio/Área Científica] ,Diagnóstico ,Dentin desensitizing agents ,Diagnosis ,Hipersensibilidade dentinária ,Dentin hypersensitivity - Abstract
Submitted by azevedo@ufp.pt (azevedo@ufp.pt) on 2017-09-11T15:07:29Z No. of bitstreams: 1 PPG_34523.pdf: 246032 bytes, checksum: 7af725aa87f8b1dd396014fe7ec8c071 (MD5) Approved for entry into archive by halves@ufp.pt (halves@ufp.pt) on 2017-09-15T18:24:49Z (GMT) No. of bitstreams: 1 PPG_34523.pdf: 246032 bytes, checksum: 7af725aa87f8b1dd396014fe7ec8c071 (MD5) Made available in DSpace on 2017-09-15T18:24:49Z (GMT). No. of bitstreams: 1 PPG_34523.pdf: 246032 bytes, checksum: 7af725aa87f8b1dd396014fe7ec8c071 (MD5) Previous issue date: 2017-06-14
- Published
- 2017
177. uma abordagem contemporânea
- Author
-
Ortolani, Alexandre Tassinari and Monteiro, Beatriz
- Subjects
Agentes dessensibilizantes dentinários ,Treatment ,Tratamento ,Dentin sensitivity ,Dentina sensível ,Ciências Médicas::Medicina Clínica [Domínio/Área Científica] ,Diagnóstico ,Dentin desensitizing agents ,Diagnosis ,Hipersensibilidade dentinária ,Dentin hypersensitivity - Abstract
A hipersensibilidade dentinária é caracterizada pela perda de esmalte e de cemento na região cervical dos dentes e consequente exposição dos túbulos dentinários que levam a uma condição dolorosa e de desconforto pelo aparecimento de dor aguda, de curta duração e intensidade variável, como resposta exacerbada a um estímulo sensorial não patológico. O objectivo deste trabalho é discutir aspectos importantes sobre hipersensibilidade, sua etiologia multifatorial, teoria de mecanismo da dor, prevalência, bem como a variedade e efetividade de tratamentos para alívio da dor nos dias actuais. Esta monografia foi baseada numa revisão bibliográfica em bibliotecas online. Muitos tratamentos têm sido propostos, mas nenhum universalmente aceite como tratamento definitivo ou altamente confiável, sendo as pastas dentifrícias com arginina o melhor custo benefício. Porém, dependendo da intensidade da hipersensibilidade, uma combinação de instrução de higiene oral, pastas dentifrícias dessensibilizantes e tratamento clínico profissional podem ser requeridos. Dentin hypersensitivity is characterized by the loss of enamel and cementum in the cervical region of the teeth and consequent exposure of the dentinal tubules that lead to a painful condition and discomfort due to the appearance of acute pain, short duration and variable intensity, as a response Exacerbated by a non-pathological sensory stimulus. The objective of this work is to discuss important aspects of hypersensitivity, its multifactorial etiology, mechanism of pain, prevalence, as well as the variety and effectiveness of treatments for pain relief in the present day. This monograph was based on a bibliographical review in renowned online libraries. Many treatments have been proposed but no universally accepted as definitive or highly reliable treatment, with arginine toothpastes being the most cost-effective, but depending on the intensity of hypersensitivity, a combination of oral hygiene instruction, use of desensitizing pastes and professional clinical treatment may be required.
- Published
- 2017
178. Parâmetros macroestéticos a avaliar numa reabilitação oral do setor anterior
- Author
-
Alves, Tatiana Andreia Sequeira and Monteiro, Beatriz
- Subjects
Facial aesthetics ,Facial analysis ,Gummy smile ,Aesthetics ,Esthetic parameters ,Smile analysis ,Gingival display ,Anterior teeth ,Smile design ,Macroesthetic elements AND smile ,Orthodontics AND smile ,Golden proportion ,Divine proportion ,Golden rule ,Esthetic dentistry ,Gingival aesthetics ,Macroaesthetics - Abstract
Projeto de Pós-Graduação/Dissertação apresentado à Universidade Fernando Pessoa como parte dos requisitos para obtenção do grau de Mestre em Medicina Dentária Hoje em dia, a estética desempenha um papel determinante na vida de uma pessoa. Um sorriso esteticamente agradável pode aumentar a autoestima e levar a uma melhor aceitação por parte da sociedade. O objetivo principal de um tratamento dentário estético é conceber uma aparência natural e saudável aos dentes. O médico dentista não pode cingir-se à condição de um ou de um grupo de dentes a serem tratados, deve adquirir uma visão mais ampla (macroestética). A macroestética representa as relações entre a face, os lábios, a gengiva e os dentes na obtenção de um resultado estético integral. Para um correto plano de tratamento e conceção de um sorriso ideal e harmonioso é necessário, previamente, uma avaliação detalhada de parâmetros faciais, periodontais e que envolvam dentes em grupo. Porém, os profissionais não devem prender-se totalmente a padrões de estética, devendo apenas utilizá-los como guias para iniciar um plano de tratamento adequado a cada paciente. Foi elaborada uma proposta de checklist / ficha clínica que possa ser utilizada pelo médico dentista para a avaliação do sorriso de um paciente em consultório, de maneira a facilitar o diagnóstico e a elaboração de um plano de tratamento. Desta checklist fazem parte os parâmetros macroestéticos (faciais, periodontais e dentários) mais relevantes abordados ao longo deste trabalho. Os objetivos principais deste trabalho de revisão narrativa contemplam (1) a revisão bibliográfica acerca do tema, (2) a descrição dos parâmetros a avaliar na face, no periodonto e no 2º sextante, quando se pretende a reabilitação estética deste sector, e da forma como estes se relacionam entre si, (3) contextualização da proporção divina a parâmetros faciais e dentários e (4) desenvolvimento de uma checklist com os parâmetros de maneira a ser utilizada na análise de um sorriso. A pesquisa realizada decorreu entre Janeiro e Maio de 2014, recorrendo-se principalmente a uma base de dados, PubMed. Foram utilizadas as seguintes palavras-chave: “aesthetics”, “anterior teeth”, “smile design”, “smile analysis”, “esthetic dentistry”, “golden proportion”, “esthetic parameters”, facial analysis”, “facial aesthetics”, “macroesthetic elements AND smile”, “macroaesthetics”, “gummy smile”, “orthodontics AND smile”, “golden rule”, “divine proportion”, “gingival aesthetics” e “gingival display”, e foram incluídos: (1) artigos publicados nos últimos 14 anos, (2) em língua portuguesa e inglesa, (3) free full text, (4) tipo de artigo: revisão narrativa, revisão sistemática, meta-análise, estudos observacionais e ensaios clínicos. Nowadays, the role of esthetics is determinant in a person’s life. An aesthetically pleasant smile can improve the self-esteem and can lead to a greater society acceptance. The main purpose of a dental esthetic treatment is to conceive a natural and healthy dental appearance. The dentist can’t limit the treatment of one or a group of teeth, he/she must acquire a wider view (macroesthetics). Macroesthetics represent the relations between the face, the lips, the gum and the teeth to obtain a whole esthetic result. To achieve a correct treatment plan and design an ideal and harmonious smile is required, previously, a detailed assessment of facial and periodontal parameters and aspects involving the teeth as a group. However, professionals shouldn’t stick entirely to aesthetical standards, they should use them as guides to initiate a suitable treatment plan for each patient. In this work, it was elaborated a checklist/clinical record proposal that can be used by dentists for the evaluation of patients’ smiles, in order to facilitate the diagnosis and the elaboration of the treatment plan. The macroesthetics parameters (facial, periodontal and dental) developed throughout this work were included in this checklist proposal. The main objectives of this narrative review contemplated: (1) the literature review of the topic, (2) the description of the facial, periodontal and 2nd sextant parameters to evaluate when seeking an esthetic rehabilitation of this sector, and how these parameters relate to each other, (3) contextualization of the divine proportion to facial and dental parameters, (4) development of a checklist with the parameters to be used in the analysis of a smile. The survey coursed between January and May of 2014, resorting mainly to the data base PubMed. The keywords used were: “aesthetics”, “anterior teeth”, “smile design”, “smile analysis”, “esthetic dentistry”, “golden proportion”, “esthetic parameters”, facial analysis”, “facial aesthetics”, “macroesthetic elements AND smile”, “macroaesthetics”, “gummy smile”, “orthodontics AND smile”, “golden rule”, “divine proportion”, “gingival aesthetics” e “gingival display”, and the methodology research included: (1) articles published in the last 14 years, (2) in Portuguese and English, (3) free full text, (4) article type: narrative reviews, systematic reviews, meta-analyzes, observational studies and clinical trials.
- Published
- 2014
179. 2024 ISFM and AAFP consensus guidelines on the long-term use of NSAIDs in cats.
- Author
-
Taylor S, Gruen M, KuKanich K, X Lascelles BD, Monteiro BP, Sampietro LR, Robertson S, and Steagall PV
- Subjects
- Cats, Animals, Humans, Anti-Inflammatory Agents, Non-Steroidal adverse effects, Pain Management veterinary, Chronic Pain veterinary, Renal Insufficiency, Chronic veterinary, Veterinarians, Cat Diseases drug therapy
- Abstract
Practical Relevance: Non-steroidal anti-inflammatory drugs (NSAIDs) are widely used and are effective for the management of pain in cats. These Guidelines will support veterinarians in decision-making around prescribing NSAIDs in situations of chronic pain, to minimise adverse effects and optimise pain management. Information is provided on mechanism of action, indications for use, screening prior to prescription, use in the presence of comorbidities, monitoring of efficacy, and avoidance and management of adverse effects., Clinical Challenges: The cat's unique metabolism should be considered when prescribing any medications, including NSAIDs. Chronic pain may be challenging to detect in this species and comorbidities, particularly chronic kidney disease, are common in senior cats. Management of chronic pain may be complicated by prescription of other drugs with the potential for interactions with NSAIDs., Evidence Base: These Guidelines have been created by a panel of experts brought together by the International Society of Feline Medicine (ISFM) and American Association of Feline Practitioners (AAFP). Information is based on the available literature, expert opinion and the panel members' experience., Competing Interests: Conflict of interestMembers of the panel have received financial remuneration for providing educational material, speaking at conferences and/or consultancy work, including from pharmaceutical companies producing NSAIDs used in cats; however, none of these activities cause any direct conflict of interest in relation to these Guidelines. Specific relevant details are given below.✜ Samantha Taylor Provision of education materials, consultancy work and speaking at conferences: Boehringer Ingelheim; Dechra; Vetoquinol; Norbrook; Zoetis.✜ Margaret Gruen Funded research: Boehringer Ingelheim. Consultancy: American Regent; Assisi; Elanco; Zoetis.✜ Kate KuKanich Provision of education materials, consultancy work and speaking at conferences. Director of Kansas State Veterinary Research Scholars Program which receives funding for research including from Boehringer Ingelheim.✜ B Duncan X Lascelles Funded research: Boehringer Ingelheim; Elanco. Private client donations: Virbac; Zoetis. Consultancy: Boehringer Ingelheim; Elanco; Vetoquinol; Zoetis.✜ Beatriz P Monteiro Consultancy: Boehringer Ingelheim; Elanco; Vetoquinol; Zoetis. Dr Monteiro currently works as a full-time employee of Zoetis; however, her contribution to these Guidelines was completed prior to this employment.✜ Llibertat Real Sampietro No conflicts of interest.✜ Sheilah Robertson Provision of education materials, consultancy work and speaking at conferences: Elanco, Zoetis.✜ Paulo V Steagall Consultancy: Boehringer Ingelheim; Dechra; Elanco; Zoetis. Key opinion leader: Boehringer Ingelheim; Dechra; Elanco; Vetoquinol; Zoetis. Speaker honoraria: Boehringer Ingelheim; Dechra; Elanco; Zoetis.
- Published
- 2024
- Full Text
- View/download PDF
180. Construct validity, responsiveness and reliability of the Feline Grimace Scale in kittens.
- Author
-
Cheng AJ, Malo A, Garbin M, Monteiro BP, and Steagall PV
- Subjects
- Animals, Cats, Female, Pain Measurement veterinary, Pain Measurement methods, Prospective Studies, Reproducibility of Results, Acute Pain veterinary, Analgesia veterinary
- Abstract
Objectives: The aim of the present study was to investigate the construct validity, responsiveness and reliability of the Feline Grimace Scale (FGS) in kittens., Methods: A total of 36 healthy female kittens (aged 10 weeks to 6 months) were included in a prospective, randomized, blinded study. Video recordings of all kittens were made before and 1 and 2 h after ovariohysterectomy using an opioid-free injectable anesthetic protocol with or without multimodal analgesia. Additional recordings were taken before and 1 h after administration of rescue analgesia (buprenorphine 0.02 mg/kg IM) to painful kittens. Screenshots of facial images were collected from the video recordings for FGS scoring. Four observers blinded to treatment groups and time points scored 111 randomized images twice with a 5-week interval using the FGS. Five action units (AUs) were scored (ear position, orbital tightening, muzzle tension, whiskers position and head position; 0-2 each). Construct validity, responsiveness, and inter- and intra-rater reliability were evaluated using linear models with Benjamini-Hochberg correction, Wilcoxon signed-rank test and single intraclass correlation coefficients (ICC
single ), respectively ( P <0.05)., Results: FGS total ratio scores were higher at 1 and 2 h after ovariohysterectomy (median [interquartile range, IQR]: 0.30 [0.20-0.40] and 0.30 [0.20-0.40], respectively) than at baseline (median [IQR]: 0.10 [0.00-0.30]) ( P <0.001). FGS total ratio scores were lower after the administration of rescue analgesia (median [IQR] before and after rescue analgesia) 0.40 [0.20-0.50] and 0.20 [0.10-0.38], respectively ( P <0.001). Inter-rater ICCsingle was 0.68 for the FGS total ratio scores and 0.35-0.70 for all AUs considered individually. Intra-rater ICCsingle was 0.77-0.91 for the FGS total ratio scores and 0.55-1.00 for all AUs considered individually., Conclusions and Relevance: The FGS is a valid and responsive acute pain-scoring instrument with moderate inter-rater reliability and good to excellent intra-rater reliability in kittens., Competing Interests: Conflict of interestThe authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.- Published
- 2023
- Full Text
- View/download PDF
181. Randomised, prospective, blinded, clinical trial of opioid-free injectable anaesthesia with or without multimodal analgesia in kittens undergoing ovariohysterectomy.
- Author
-
Malo A, Cheng AJ, Ruel HL, Monteiro BP, Lutevele N, Marangoni S, Garbin M, Watanabe R, and Steagall PV
- Subjects
- Single-Blind Method, Animals, Cats, Female, Analgesics, Opioid, Ketamine administration & dosage, Ketamine therapeutic use, Dexmedetomidine administration & dosage, Dexmedetomidine therapeutic use, Midazolam administration & dosage, Midazolam therapeutic use, Meloxicam administration & dosage, Meloxicam therapeutic use, Bupivacaine administration & dosage, Bupivacaine therapeutic use, Eating, Injections, Intramuscular, Pain Measurement veterinary, Hysterectomy, Ovariectomy, Anesthesia methods, Pain, Postoperative diagnosis, Pain, Postoperative drug therapy, Pain, Postoperative prevention & control, Pain, Postoperative veterinary
- Abstract
Objectives: This study compared an opioid-free injectable anaesthetic protocol with or without multimodal analgesia in kittens undergoing ovariohysterectomy., Methods: In this prospective, randomised, blinded, clinical trial, 29 healthy kittens (mean ± SD weight 1.55 ± 0.46 kg; aged 10 weeks to 6 months) were included. Anaesthesia was performed with an intramuscular injection of ketamine (4 mg/kg), dexmedetomidine (40 μg/kg) and midazolam (0.25 mg/kg). In the multimodal group (MMG), cats (n = 14) received meloxicam (0.1 mg/kg SC) and intraperitoneal bupivacaine 0.25% (2 mg/kg), whereas the same volume of saline was administered in the control group (CG; n = 15). Atipamezole (0.4 mg/kg IM) was given 15 mins after ovariohysterectomy. Postoperative pain was assessed using the UNESP-Botucatu multidimensional feline pain assessment scale - short form. Rescue analgesia (buprenorphine 0.02 mg/kg IM in MMG/CG and meloxicam 0.1 mg/kg SC in CG) was administered if pain scores were ⩾4/12. Soft food intake (after 2 and 60 mins) was evaluated at specific time points postoperatively. Statistical analyses were performed with linear models and post-hoc pairwise comparison with Benjamini-Hochberg corrections ( P <0.05)., Results: The prevalence of rescue analgesia was higher in the CG (n = 15/15) than the MMG (n = 1/14; P <0.001). Pain scores at 1 h, 2 h and 4 h postoperatively were higher in the CG (4.1 ± 2.8, 4.8 ± 3.0 and 5.3 ± 1.2, respectively) than in the MMG (1.6 ± 1.0, 1.1 ± 1.0 and 0.9 ± 0.8, respectively; P <0.001). Food intake (%) at 1 h postoperatively was higher in the MMG after 2 and 60 mins (10.4 ± 9 and 71.9 ± 29, respectively) than in the CG (1.4 ± 2 and 13.9 ± 7, respectively; P <0.001)., Conclusions and Relevance: This opioid-free protocol using multimodal analgesia produced adequate postoperative pain relief, while almost eliminating the need for rescue analgesia in kittens undergoing ovariohysterectomy. Pain decreased food intake.
- Published
- 2023
- Full Text
- View/download PDF
182. Analgesic efficacy of an ultrasound-guided transversus abdominis plane block with bupivacaine in cats: a randomised, prospective, masked, placebo-controlled clinical trial.
- Author
-
Garbin M, Ruel HL, Watanabe R, Malo A, Monteiro BP, and Steagall PV
- Subjects
- Animals, Cats, Female, Abdominal Muscles, Analgesics, Meloxicam, Pain veterinary, Prospective Studies, Ultrasonography, Interventional veterinary, Bupivacaine therapeutic use, Buprenorphine therapeutic use
- Abstract
Objectives: This randomised, prospective, masked clinical trial evaluated the postoperative analgesic efficacy of an ultrasound-guided transversus abdominis plane block (TAPB) with bupivacaine in cats undergoing ovariohysterectomy., Methods: Thirty-two healthy adult female cats undergoing elective ovariohysterectomy were randomised to undergo TAPB with bupivacaine (treatment group [TG], n = 16) vs placebo (control group [CG], n = 16) in addition to preoperative analgesia with buprenorphine (0.02 mg/kg IM). All patients received a general anaesthetic and, before surgical incision, a bilateral two-point (subcostal and lateral-longitudinal) TAPB was performed using 1 ml/kg bupivacaine 0.25% (0.25 ml/kg/point) or saline. Each cat was assessed by a blinded investigator before premedication (0 h) and at 1, 2, 3, 4, 8, 10 and 24 h postoperatively using the UNESP-Botucatu Feline Pain Scale - short form. Buprenorphine (0.02 mg/kg IV) and meloxicam (0.2 mg/kg SC) were administered when pain scores were ⩾4/12. Ten hours postoperatively, meloxicam was administered to cats that did not receive rescue analgesia. Statistical analysis included Student's t -tests, Wilcoxon tests and χ
2 tests, and a linear mixed model with Bonferroni corrections ( P <0.05)., Results: Of the 32 cats enrolled, three in the CG were excluded from the analysis. The prevalence of rescue analgesia was significantly higher in the CG (n = 13/13) than in the TG (n = 3/16; P <0.001). Only one cat in the CG required rescue analgesia twice. Pain scores were significantly higher in the CG compared with the TG at 2, 4 and 8 h postoperatively. Mean ± SD pain scores were significantly higher in the CG, but not in the TG, at 2 (2.1 ± 1.9), 3 (1.9 ± 1.6), 4 (3.0 ± 1.4) and 8 h postoperatively (4.7 ± 0.6) than at 0 h (0.1 ± 0.3)., Conclusions and Relevance: A bilateral ultrasound-guided two-point TAPB with bupivacaine in combination with systemic buprenorphine provided superior postoperative analgesia than buprenorphine alone in cats undergoing ovariohysterectomy.- Published
- 2023
- Full Text
- View/download PDF
183. Measurement properties of pain scoring instruments in farm animals: A systematic review using the COSMIN checklist.
- Author
-
Tomacheuski RM, Monteiro BP, Evangelista MC, Luna SPL, and Steagall PV
- Subjects
- Animals, Sheep, Cattle, Swine, Reproducibility of Results, Farms, Pain diagnosis, Pain veterinary, Psychometrics, Checklist, Animals, Domestic
- Abstract
This systematic review aimed to investigate the measurement properties of pain scoring instruments in farm animals. According to the PRISMA guidelines, a registered report protocol was previously published in this journal. Studies reporting the development and validation of acute and chronic pain scoring instruments based on behavioral and/or facial expressions of farm animals were searched. Data extraction and assessment were performed individually by two investigators using the Consensus-based Standards for the Selection of Health Measurement Instruments (COSMIN) guidelines. Nine categories were assessed: two for scale development (general design requirements and development, and content validity and comprehensibility) and seven for measurement properties (internal consistency, reliability, measurement error, criterion and construct validity, responsiveness and cross-cultural validity). The overall strength of evidence (high, moderate, low, or very low) of each instrument was scored based on methodological quality, number of studies and studies' findings. Twenty instruments for three species (bovine, ovine and swine) were included. There was considerable variability concerning their development and measurement properties. Three behavior-based instruments scored high for strength of evidence: UCAPS (Unesp-Botucatu Unidimensional Composite Pain Scale for assessing postoperative pain in cattle), USAPS (Unesp-Botucatu Sheep Acute Composite Pain Scale) and UPAPS (Unesp-Botucatu Pig Composite Acute Pain Scale). Four instruments scored moderate for strength of evidence: MPSS (Multidimensional Pain Scoring System for bovine), SPFES (Sheep Pain Facial Expression Scale), LGS (Lamb Grimace Scale) and PGS-B (Piglet Grimace Scale-B). Most instruments (n = 13) scored low or very low for final overall evidence. Construct validity was the most reported measurement property followed by criterion validity and reliability. Instruments with reported validation are urgently required for pain assessment of buffalos, goats, camelids and avian species., Competing Interests: The authors have declared that no competing interests exist., (Copyright: © 2023 Tomacheuski et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.)
- Published
- 2023
- Full Text
- View/download PDF
184. Can cat caregivers reliably assess acute pain in cats using the Feline Grimace Scale? A large bilingual global survey.
- Author
-
Monteiro BP, Lee NH, and Steagall PV
- Subjects
- Cats, Male, Animals, Female, Humans, Caregivers, Reproducibility of Results, Pain Measurement veterinary, Pain Measurement methods, Pain Management veterinary, Acute Pain veterinary, Cat Diseases
- Abstract
Objectives: This study aimed to investigate if cat caregivers could reliably assess acute pain using the Feline Grimace Scale (FGS), and if participant demographics could affect scores., Methods: An online survey in English and Spanish was advertised by International Cat Care and other platforms (March-May 2021) using convenience sampling. Eligible participants were caregivers >18 years old and non-veterinary health professionals. Participants and a group of eight veterinarians scored 10 images of cats with different levels of pain. Data were analysed using linear models and intraclass correlation coefficient (ICC; α <0.05). Interpretation of the ICC was <0.2 = poor; 0.21-0.4 = reasonable; 0.41-0.60 = moderate; 0.61-0.80 = good; and 0.81-1.0 = very good., Results: A total of 3039 responses were received with 1262 completed answers from 66 countries (86%, 11.1% and 2.9% identified as female, male or other, respectively). Scores for each action unit (AU; ear position, orbital tightening, muzzle tension, whiskers change and head position) and their sum (FGS score) were not significantly different between caregivers and veterinarians, except for muzzle (caregivers 0.9 ± 0.0; veterinarians 0.7 ± 0.1; P = 0.035). The ICC single (caregivers) was 0.65, 0.69, 0.58, 0.37, 0.38 and 0.65, respectively, for AU ears, eyes, muzzle, whiskers, head and sum of scores. Demographic variables did not affect FGS scores., Conclusions and Relevance: Total FGS scores had good reliability when used by cat caregivers, regardless of demographic variables, showing the potential applicability of the instrument to improve feline pain management and welfare worldwide.
- Published
- 2023
- Full Text
- View/download PDF
185. A randomized, prospective, masked clinical trial comparing an opioid-free vs. opioid-sparing anesthetic technique in adult cats undergoing ovariohysterectomy.
- Author
-
Rufiange M, Ruel HLM, Monteiro BP, Watanabe R, Cruz Benedetti IC, Benito J, and Steagall PVM
- Abstract
This study aimed to compare the analgesic effects of an injectable protocol using multimodal analgesia with or without opioids in cats undergoing ovariohysterectomy (OVH). Thirty-two healthy cats were enrolled in a prospective, blinded, randomized trial after the caregiver's written consent. Cats received a combination of ketamine (4 mg/kg), midazolam (0.25 mg/kg) and dexmedetomidine (40 μg/kg), and either buprenorphine (20 μg/kg) or saline (same volume as buprenorphine) intramuscularly [opioid-sparing (OSA) and opioid-free anesthesia (OFA) groups, respectively]. Intraperitoneal bupivacaine 0.25% (2 mg/kg) and meloxicam (0.2 mg/kg subcutaneously) were administered before OVH. Atipamezole (400 μg/kg intramuscularly) was administered at the end of surgery. Pain and sedation were evaluated using the Feline Grimace Scale (FGS) and a dynamic interactive visual analog scale, respectively. Intravenous buprenorphine was administered as rescue analgesia if FGS scores ≥ 0.39/1. Statistical analysis included repeated measures linear mixed models, Fisher's exact test and Bonferroni adjustments when appropriate ( p < 0.05). Twenty-seven cats were included. The prevalence of rescue analgesia was lower in OSA ( n = 0/13) than in OFA ( n = 5/14) ( p = 0.04). The FGS scores (least square means and 95% CI) were higher in OFA at 1 [2.0 (1.3-2.7)] and 2 h [2.2 (1.5-2.9)] than baseline [0.7 (0.0-1.4)], but not in OSA. Sedation scores were not significantly different between groups. Opioid-free injectable anesthesia was appropriate for some cats using a multimodal approach. However, a single dose of intramuscular buprenorphine eliminated the need for rescue analgesia and assured adequate pain management after OVH in cats., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2022 Rufiange, Ruel, Monteiro, Watanabe, Cruz Benedetti, Benito and Steagall.)
- Published
- 2022
- Full Text
- View/download PDF
186. Pharmacokinetics of Bupivacaine Following Administration by an Ultrasound-Guided Transversus Abdominis Plane Block in Cats Undergoing Ovariohysterectomy.
- Author
-
Garbin M, Benito J, Ruel HLM, Watanabe R, Monteiro BP, Cagnardi P, and Steagall PV
- Abstract
Bupivacaine is commonly used for peripheral nerve block in veterinary medicine. This study described the pharmacokinetics of two doses of bupivacaine following administration by an ultrasound-guided transversus abdominis plane (TAP) block in cats undergoing ovariohysterectomy. Twelve healthy female adult cats were included in a randomized, prospective, blinded clinical trial. Anaesthetic protocol included acepromazine-buprenorphine-propofol-isoflurane-meloxicam. Each cat received 1 mL/kg of bupivacaine 0.2% or 0.25% (BUPI-2 and BUPI-2.5, respectively) via bilateral two-point TAP block before surgery (n = 6/group). Plasma concentrations of bupivacaine were detected using liquid chromatography-mass spectrometry. A one-compartment model and non-compartmental analysis described the pharmacokinetic parameters. Bupivacaine was detected up to 480 min (335 ± 76 in BUPI-2 and 485 ± 198 ng/mL in BUPI-2.5). For BUPI-2 and BUPI-2.5, maximum plasma concentrations were 1166 ± 511 and 1810 ± 536 ng/mL at 33 ± 14 and 47 ± 22 min, clearance was 5.3 ± 1.8 and 4.9 ± 1.5 mL/min/kg, and elimination half-life were 253 ± 55 and 217 ± 52 min, respectively. The two doses of bupivacaine via TAP block produced concentrations below toxic levels in cats. A dose of 2.5 mg/kg bupivacaine was safe to be administered using this block in healthy cats.
- Published
- 2022
- Full Text
- View/download PDF
187. Measurement properties of grimace scales for pain assessment in nonhuman mammals: a systematic review.
- Author
-
Evangelista MC, Monteiro BP, and Steagall PV
- Subjects
- Animals, Cats, Horses, Mice, Pain diagnosis, Pain veterinary, Pain Measurement, Psychometrics, Rabbits, Rats, Reproducibility of Results, Sheep, Swine, Facial Expression, Ferrets
- Abstract
Abstract: Facial expressions of pain have been identified in several animal species. The aim of this systematic review was to provide evidence on the measurement properties of grimace scales for pain assessment. The protocol was registered (SyRF#21-November-2019), and the study is reported according to the PRISMA guidelines. Studies reporting the development, validation, and the assessment of measurement properties of grimace scales were included. Data extraction and assessment were performed by 2 investigators, following the COnsensus-based Standards for the Selection of Health Measurement INstruments guidelines. Six categories of measurement properties were assessed: internal consistency, reliability, measurement error, criterion and construct validity, and responsiveness. Overall strength of evidence (high, moderate, and low) of each instrument was based on methodological quality, number of studies, and studies' findings. Twelve scales for 9 species were included (mice, rats, rabbits, horses, piglets, sheep or lamb, ferrets, cats, and donkeys). Considerable variability regarding their development and measurement properties was observed. The Mouse, Rat, Horse and Feline Grimace Scales exhibited high level of evidence. The Rabbit, Lamb, Piglet and Ferret Grimace Scales and Sheep Pain Facial Expression Scale exhibited moderate level of evidence. The Sheep Grimace Scale, EQUUS-FAP, and EQUUS-Donkey-FAP exhibited low level of evidence for measurement properties. Construct validity was the most reported measurement property. Reliability and other forms of validity have been understudied. This systematic review identified gaps in knowledge on the measurement properties of grimace scales. Further studies should focus on improving psychometric testing, instrument refinement, and the use of grimace scales for pain assessment in nonhuman mammals., (Copyright © 2021 International Association for the Study of Pain.)
- Published
- 2022
- Full Text
- View/download PDF
188. Multilingual validation of the short form of the Unesp-Botucatu Feline Pain Scale (UFEPS-SF).
- Author
-
Luna SPL, Trindade PHE, Monteiro BP, Crosignani N, Della Rocca G, Ruel HLM, Yamashita K, Kronen P, Tseng CT, Teixeira L, and Steagall PV
- Subjects
- Cats, Animals, Reproducibility of Results, Language, Translating, Pain, Postoperative diagnosis, Analgesia veterinary
- Abstract
Background: Pain is the leading cause of animal suffering, hence the importance of validated tools to ensure its appropriate evaluation and treatment. We aimed to test the psychometric properties of the short form of the Unesp-Botucatu Feline Pain Scale (UFEPS-SF) in eight languages., Methods: The original scale was condensed from ten to four items. The content validation was performed by five specialists in veterinary anesthesia and analgesia. The English version of the scale was translated and back-translated into Chinese, French, German, Italian, Japanese, Portuguese and Spanish by fluent English and native speaker translators. Videos of the perioperative period of 30 cats submitted to ovariohysterectomy (preoperative, after surgery, after rescue analgesia and 24 h after surgery) were randomly evaluated twice (one-month interval) by one evaluator for each language unaware of the pain condition. After watching each video, the evaluators scored the unidimensional, UFEPS-SF and Glasgow composite multidimensional feline pain scales. Statistical analyses were carried out using R software for intra and interobserver reliability, principal component analysis, criteria concurrent and predictive validities, construct validity, item-total correlation, internal consistency, specificity, sensitivity, the definition of the intervention score for rescue analgesia and diagnostic uncertainty zone, according to the receiver operating characteristic (ROC) curve., Results: UFEPS-SF intra- and inter-observer reliability were ≥0.92 and 0.84, respectively, for all observers. According to the principal component analysis, UFEPS-SF is a unidimensional scale. Concurrent criterion validity was confirmed by the high correlation between UFEPS-SF and all other scales (≥0.9). The total score and all items of UFEPS-SF increased after surgery (pain), decreased to baseline after analgesia and were intermediate at 24 h after surgery (moderate pain), confirming responsiveness and construct validity. Item total correlation of each item (0.68-0.83) confirmed that the items contributed homogeneously to the total score. Internal consistency was excellent (≥0.9) for all items. Both specificity (baseline) and sensitivity (after surgery) based on the Youden index was 99% (97-100%). The suggestive cut-off score for the administration of analgesia according to the ROC curve was ≥4 out of 12. The diagnostic uncertainty zone ranged from 3 to 4. The area under the curve of 0.99 indicated excellent discriminatory capacity of UFEPS-SF., Conclusions: The UFEPS-SF and its items, assessed by experienced evaluators, demonstrated very good repeatability and reproducibility, content, criterion and construct validities, item-total correlation, internal consistency, excellent sensitivity and specificity and a cut-off point indicating the need for rescue analgesia in Chinese, French, English, German, Italian, Japanese, Portuguese and Spanish., Competing Interests: The authors declare there are no competing interests., (©2022 Luna et al.)
- Published
- 2022
- Full Text
- View/download PDF
189. The thermal antinociceptive effects of a high-concentration formulation of buprenorphine alone or followed by hydromorphone in conscious cats.
- Author
-
Moreno KL, Scallan EM, Monteiro BP, Steagall PV, and Simon BT
- Subjects
- Analgesics, Analgesics, Opioid pharmacology, Animals, Cats, Cross-Over Studies, Female, Buprenorphine pharmacology, Hydromorphone pharmacology
- Abstract
Objective: To evaluate the thermal antinociceptive effects of a high-concentration formulation of buprenorphine alone or followed by hydromorphone in conscious cats., Study Design: Randomized, blinded, placebo-controlled crossover study design., Animals: A total of six purpose-bred, adult female ovariohysterectomized Domestic Short Hair cats., Methods: Cats were allocated into three treatments each consisting of two injections, subcutaneous then intravenous (IV) administration, 2 hours apart: treatment SS, two injections of 0.9% saline; treatment BS, buprenorphine (0.24 mg kg
-1 , 1.8 mg mL-1 ) and saline; and treatment BH, buprenorphine (0.24 mg kg-1 ) and hydromorphone (0.1 mg kg-1 ). Skin temperature (ST) and thermal threshold (TT) were recorded before (baseline) and for 24 hours following first injection. TT data were analyzed using mixed linear models and a Benjamini-Hochberg sequential adjustment procedure (p < 0.05)., Results: There were no significant differences among treatments for baseline ST and TT values, treatment SS over time and between treatments BS and BH. Compared with baseline, TT was significantly increased at all time points in treatments BH and BS except at 2 hours in treatment BS. TT was significantly higher than SS at 3-18 hours and 4-12 hours for treatments BS and BH, respectively. Maximal increases in TT were 47.5 °C at 2 hours, 53.9 °C at 3 hours and 52.4 °C at 6 hours in treatments SS, BS and BH, respectively., Conclusions and Clinical Relevance: Administration of IV hydromorphone following high-concentration buprenorphine provided no additional antinociception and decreased the duration of effect when compared with high-concentration buprenorphine alone. Alternative analgesics should be considered if additional analgesia is required after administration of high-concentration buprenorphine., (Copyright © 2021 Association of Veterinary Anaesthetists and American College of Veterinary Anesthesia and Analgesia. Published by Elsevier Ltd. All rights reserved.)- Published
- 2021
- Full Text
- View/download PDF
190. Feline Chronic Pain and Osteoarthritis.
- Author
-
Monteiro BP
- Subjects
- Animals, Cats, Osteoarthritis physiopathology, Cat Diseases physiopathology, Osteoarthritis veterinary, Pain veterinary, Pain Measurement veterinary
- Abstract
This article reviews the current knowledge regarding osteoarthritis-related pain in cats as a structure in which to discuss the assessment of chronic pain in the research and clinical settings. The scientific evidence available for current and emerging drug therapies is described. The importance of environmental enrichment and positive emotions to reduce pain, stress, and anxiety as means to promote feline welfare and human-pet bond is discussed., Competing Interests: Disclosure Dr. Monteiro has provided consultancy services to Zoetis and Vetoquinol., (Copyright © 2020 Elsevier Inc. All rights reserved.)
- Published
- 2020
- Full Text
- View/download PDF
191. Anesthetic and analgesic effects of an opioid-free, injectable protocol in cats undergoing ovariohysterectomy: A prospective, blinded, randomized clinical trial.
- Author
-
Diep TN, Monteiro BP, Evangelista MC, Balleydier A, Watanabe R, Ruel HLM, Doodnaught GM, Le Quang T, and Steagall PV
- Subjects
- Analgesics, Opioid, Animals, Cats, Female, Hysterectomy veterinary, Ovariectomy veterinary, Pain, Postoperative drug therapy, Pain, Postoperative prevention & control, Pain, Postoperative veterinary, Prospective Studies, Anesthetics, Cat Diseases
- Abstract
This study evaluated the effects of ketamine-dexmedetomidine-midazolam as part of an opioid-free, multimodal protocol in cats undergoing ovariohysterectomy. In a prospective, blinded, randomized clinical trial, cats received either 1 of 2 doses of ketamine [5 mg/kg body weight (BW), n = 10, K5 or 7 mg/kg BW, n = 13, K7] with midazolam (0.25 mg/kg BW) and dexmedetomidine (40 μg/kg BW) intramuscularly, intraperitoneal bupivacaine (2 mg/kg BW) and subcutaneous meloxicam (0.2 mg/kg BW) after surgery. Buprenorphine (0.02 mg/kg BW, intravenously) was administered if pain scores exceeded intervention scores with 2 pain scoring systems. Similar prevalence of rescue analgesia was observed (K5 = 6/10; K7 = 7/13) with significantly lower requirements in kittens (2/8) than adults (11/15). Tachypnea (K5 = 7/10 and K7 = 9/13) and desaturation (K5 = 3/10 and K7 = 4/13) were the 2 most common complications. Age influenced the prevalence of rescue analgesia. Most adult cats required opioids for postoperative pain relief., (Copyright and/or publishing rights held by the Canadian Veterinary Medical Association.)
- Published
- 2020
192. Frequency of Anatomic Variations on Hepatic Arteries and Types of Reconstruction Employed: Study on Livers Prepared for Transplantation.
- Author
-
Vasconcelos-Filho JM, Magalhães PRM, Monteiro BR, Moura AA, Silva GC, Fonseca-Neto OCL, and Lacerda C
- Subjects
- Adult, Female, Hepatic Artery surgery, Humans, Liver blood supply, Male, Plastic Surgery Procedures methods, Vascular Surgical Procedures methods, Hepatic Artery abnormalities, Liver Transplantation
- Abstract
Background: Recognition of anatomic variations in the hepatic artery is important at the time of organ uptake and at the back table for transplantation., Purpose: To know the frequency of these variations, in a 5-year series of liver transplantation and the various types of arterial reconstruction used in back table surgery., Methods: We analyzed 340 donor files and calculated the frequencies of the various anatomic variations of the hepatic artery, according to Hiatt, and the types of vascular reconstruction employed., Results: In total, 225 cases (66.17%) had a single hepatic artery, considered unchanged (type I), originating from the celiac trunk. Forty-six (13.52%) and 44 (12.94%) were, respectively, type II and III. Eight cases (2.35%) had a type II and III association (type IV), and another 8 (2.35%) were type V. There were no type VI cases. Nine cases were not described in the Hiatt classification. The most common reconstruction was right hepatic and splenic artery anastomosis, performed in 53 cases (91.37%). In 4 cases, this reconstruction was performed with the gastroduodenal (6.89%). In 1 case of 3 arteries with independent origins, in the aorta, reconstruction was performed using the iliac artery graft (common and its bifurcation), taken from the organ donor (1.72%)., Conclusions: The most common variations were the presence of a left or right hepatic artery alone, each with a frequency of 13%, and the most commonly used reconstruction was the right hepatic with splenic arteries anastomosis., (Copyright © 2020. Published by Elsevier Inc.)
- Published
- 2020
- Full Text
- View/download PDF
193. Pharmacokinetics and analgesic effects of intravenous, intramuscular or subcutaneous buprenorphine in dogs undergoing ovariohysterectomy: a randomized, prospective, masked, clinical trial.
- Author
-
Steagall PV, Ruel HLM, Yasuda T, Monteiro BP, Watanabe R, Evangelista MC, and Beaudry F
- Subjects
- Administration, Intravenous veterinary, Analgesia veterinary, Analgesics, Opioid administration & dosage, Animals, Buprenorphine administration & dosage, Female, Hysterectomy veterinary, Injections, Intramuscular veterinary, Injections, Subcutaneous veterinary, Ovariectomy veterinary, Pain Measurement veterinary, Pain, Postoperative drug therapy, Prospective Studies, Analgesics, Opioid pharmacokinetics, Buprenorphine pharmacokinetics, Dogs surgery, Pain, Postoperative veterinary
- Abstract
Background: Buprenorphine is used for canine postoperative pain management. This study aimed to describe the pharmacokinetics and evaluate the analgesic efficacy of buprenorphine (Simbadol, 1.8 mg/mL) administered by different routes in dogs undergoing ovariohysterectomy. Twenty-four dogs were included in a randomized, prospective, masked, clinical trial. Buprenorphine (0.02 mg/kg) was administered intravenously (IV), intramuscularly (IM) or subcutaneously (SC) (n = 8/group) 0.5 h before general anesthesia with propofol-isoflurane. Carprofen (4.4 mg/kg SC) was administered after anesthetic induction and before ovariohysterectomy. Pain was scored using the short-form Glasgow composite pain scale for dogs (SF-GCPS). Dogs were administered morphine (0.25 mg/kg IV) when SF-GCPS scores were ≥ 5/20. Blood sampling was performed up to 720 min after drug administration. Plasma buprenorphine and norbuprenorphine concentrations were analyzed using liquid chromatography mass spectrometry. Pharmacokinetics of buprenorphine was described using a non-compartmental model (PK Solver 2.0). Statistical analysis was performed using linear mixed models and Fisher's exact test (p < 0.05)., Results: Pain scores were significantly higher than baseline after IV (0.5-2 h), IM (0.5-3 h) and SC (0.5-4 h) but not among groups. Prevalence of rescue analgesia was significantly higher in SC (7/8 dogs) than IV (2/8) but not different between IV and IM (3/8) or IM and SC. The frequency of rescue analgesia was not significantly different among groups (IV = 2, IM = 5 and SC = 9). Norbuprenorphine was not detected. For IV, IM and SC administration, clearance was 1.29, 1.65 and 1.40 L/hour/kg, volume of distribution was 6.8, 14.2 and 40.1 L/kg, the elimination half-life was 3.7, 5.7, 22 h, and the area under the plasma concentration-time curved extrapolated to infinity was 15.7, 12.4 and 16.4 ng/mL/hour, respectively. Bioavailability for IM and SC was 62.6 and 40%, respectively. Maximum plasma concentrations of buprenorphine were 6.2 and 1.3 ng/mL at 0.14 and 0.33 h after IM and SC administration, respectively., Conclusions: The route of administration influences the analgesic efficacy of buprenorphine in dogs. SC administration of buprenorphine failed to provide clinical analgesia due to erratic drug absorption. At the doses administered, the IV and IM routes are preferred for postoperative analgesia.
- Published
- 2020
- Full Text
- View/download PDF
194. Facial expressions of pain in cats: the development and validation of a Feline Grimace Scale.
- Author
-
Evangelista MC, Watanabe R, Leung VSY, Monteiro BP, O'Toole E, Pang DSJ, and Steagall PV
- Subjects
- Acute Pain diagnosis, Acute Pain veterinary, Analgesia, Animals, Case-Control Studies, Cats, Female, Male, Observer Variation, Pain diagnosis, Pain Management, Prospective Studies, Reproducibility of Results, Translational Research, Biomedical, Video Recording, Facial Expression, Pain veterinary, Pain Measurement methods, Pain Measurement veterinary
- Abstract
Grimace scales have been used for pain assessment in different species. This study aimed to develop and validate the Feline Grimace Scale (FGS) to detect naturally-occurring acute pain. Thirty-five client-owned and twenty control cats were video-recorded undisturbed in their cages in a prospective, case-control study. Painful cats received analgesic treatment and videos were repeated one hour later. Five action units (AU) were identified: ear position, orbital tightening, muzzle tension, whiskers change and head position. Four observers independently scored (0-2 for each AU) 110 images of control and painful cats. The FGS scores were higher in painful than in control cats; a very strong correlation with another validated instrument for pain assessment in cats was observed (rho = 0.86, p < 0.001) as well as good overall inter-rater reliability [ICC = 0.89 (95% CI: 0.85-0.92)], excellent intra-rater reliability (ICC > 0.91), and excellent internal consistency (Cronbach's alpha = 0.89). The FGS detected response to analgesic treatment (scores after analgesia were lower than before) and a cut-off score was determined (total pain score > 0.39 out of 1.0). The FGS is a valid and reliable tool for acute pain assessment in cats.
- Published
- 2019
- Full Text
- View/download PDF
195. Antiinflammatory Drugs.
- Author
-
Monteiro B and Steagall PV
- Subjects
- Acetaminophen therapeutic use, Animals, Dipyrone therapeutic use, Pain drug therapy, Pain Management methods, Anti-Inflammatory Agents, Non-Steroidal therapeutic use, Pain veterinary, Pain Management veterinary
- Abstract
This article reviews the mechanisms of action, clinical use, and recent scientific evidence for the use of nonsteroidal antiinflammatory drugs, grapiprant, acetaminophen (paracetamol), metamizole (dipyrone), and corticosteroids in pain management. The discussion is presented with an emphasis on the treatment of acute pain., (Copyright © 2019 Elsevier Inc. All rights reserved.)
- Published
- 2019
- Full Text
- View/download PDF
196. Safety and efficacy of reduced dosage ketoprofen with or without tramadol for long-term treatment of osteoarthritis in dogs: a randomized clinical trial.
- Author
-
Monteiro BP, Lambert C, Bianchi E, Genevois JP, Soldani G, and Troncy E
- Subjects
- Analgesics, Opioid administration & dosage, Animals, Chronic Disease drug therapy, Chronic Disease veterinary, Cyclooxygenase Inhibitors administration & dosage, Dogs, Dose-Response Relationship, Drug, Double-Blind Method, Drug Therapy, Combination, Female, Ketoprofen administration & dosage, Ketoprofen adverse effects, Male, Osteoarthritis drug therapy, Platelet Aggregation drug effects, Random Allocation, Tramadol administration & dosage, Tramadol adverse effects, Analgesics, Opioid therapeutic use, Cyclooxygenase Inhibitors therapeutic use, Dog Diseases drug therapy, Ketoprofen therapeutic use, Tramadol therapeutic use
- Abstract
Background: This study aimed to evaluate the safety and efficacy of reduced-dosage ketoprofen with or without tramadol in dogs. Five healthy dogs receiving standard-dosage ketoprofen (2 mg/kg SC, then 1 mg/kg PO daily) comprised Group A. Twenty dogs with osteoarthritis were randomized to receive reduced-dosage ketoprofen (0.5 mg/kg SC once; 0.25 mg/kg PO daily) alone (Group B) or in combination with tramadol (5 mg/kg/day PO) (Group C). Treatments were administered for 28 days. Platelet aggregation time (PAT), gastrointestinal (GI) endoscopy and glomerular filtration rate (GFR) were performed up to 60 days after treatment initiation. Pain was scored using a validated clinical metrology instrument up to D120. Data were analyzed with general linear mixed model for repeated measures (α = 0.05)., Results: PAT was not different between groups but was increased with time for all groups. GI lesion scores were higher in Group A than Groups B and C (day 28; P = 0.005) and were increased with time for Group A (P = 0.005). GFR was lower in Group A than Groups B and C (day 28; P < 0.01) and were decreased with time for group A (P < 0.001). Standard-dosage ketoprofen administration resulted in clinically relevant adverse effects. Pain score decreased in both treated groups (B and C) from D0 to D28. Need of rescue analgesia from D29 to D120 was higher in Group B than in Group C (P = 0.039)., Conclusions: The long-term safety profile of reduced-dosage ketoprofen is similar whether the drug is administered alone or in combination with tramadol to dogs with osteoarthritis. Analgesic efficacy of the combination looks attractive.
- Published
- 2019
- Full Text
- View/download PDF
197. The effects of aging on hydromorphone-induced thermal antinociception in healthy female cats.
- Author
-
Simon BT, Scallan EM, Monteiro BP, and Steagall PVM
- Abstract
Introduction: This study aimed to evaluate the effects of aging on hydromorphone-induced thermal antinociception in cats., Methods: In a prospective, randomized, blinded, controlled design, 10 healthy female cats received each of the following treatments intramuscularly: hydromorphone (0.1 mg/kg) and 0.9% saline (0.05 mL/kg) with a 1-week washout between treatments at 6, 9, and 12 months of age. Skin temperature and thermal thresholds (TTs) were recorded before and up to 12 hours after injection. Data were analyzed using a repeated-measures linear mixed model (α = 0.05)., Results: After saline treatment, TT was not significantly different from baseline at any time point for any age group. After hydromorphone treatment, TT was significantly higher than baseline at 6 months for up to 1 hour, and at 9 and 12 months for up to 4 hours. Peak TT at 6, 9, and 12 months were 50.4 ± 2.7, 50.9 ± 2.0, and 53.6 ± 2.0°C at 0.5, 1, and 1 hours, respectively. Mean TT was significantly higher after hydromorphone treatment when compared with saline treatment at 9 and 12 months for up to 4 hours but not at 6 months. Magnitude of antinociception was consistently larger at 12 months when compared with 6 months of age. Hydromorphone provided a shorter duration and smaller magnitude of antinociception at 6 months when compared with 9 and 12 months., Conclusion: Pediatric cats may require more frequent dosing of hydromorphone than adults., Competing Interests: Sponsorships or competing interests that may be relevant to content are disclosed at the end of this article.
- Published
- 2019
- Full Text
- View/download PDF
198. The analgesic effects of buprenorphine (Vetergesic or Simbadol) in combination with carprofen in dogs undergoing ovariohysterectomy: a randomized, blinded, clinical trial.
- Author
-
Watanabe R, Monteiro BP, Evangelista MC, Castonguay A, Edge D, and Steagall PV
- Subjects
- Analgesics, Opioid administration & dosage, Animals, Anti-Inflammatory Agents, Non-Steroidal administration & dosage, Dogs surgery, Drug Therapy, Combination, Female, Hysterectomy veterinary, Ovariectomy veterinary, Pain Measurement veterinary, Pain, Postoperative prevention & control, Preanesthetic Medication veterinary, Prospective Studies, Buprenorphine administration & dosage, Carbazoles administration & dosage, Dogs physiology, Pain, Postoperative veterinary
- Abstract
Background: Buprenorphine is a potent lipophilic opioid analgesic that is largely used in the multimodal treatment of acute pain. Simbadol (buprenorphine hydrochloride) is the first and only FDA-approved high-concentration formulation of buprenorphine for use in cats. The aim of this study was to evaluate the analgesic efficacy of carprofen in combination with one of two commercial formulations of buprenorphine (Simbadol and Vetergesic, 1.8 mg/mL and 0.3 mg/mL, respectively) in dogs undergoing ovariohysterectomy. Twenty-four dogs were included in a randomized, prospective, controlled, clinical trial. Patients were randomly divided into 2 groups as follows. Dogs were premedicated with acepromazine (0.02 mg/kg) and either 0.02 mg/kg of Vetergesic or Simbadol intramuscularly (Vetergesic group - VG; Simbadol group - SG, respectively; n = 12/group). General anesthesia was induced with propofol and maintained with isoflurane in 100% oxygen. Carprofen (4.4 mg/kg SC) was administered after induction of anesthesia. Heart rate, respiratory rate, blood pressure, pulse oximetry, pain scores using the Glasgow Composite Pain Scale Short Form (CMPS-SF), sedation scores using a dynamic interactive visual analogue scale and adverse events were evaluated before and after ovariohysterectomy by an observer who was unaware of treatment administration. If CMPS-SF scores were ≥ 5/20, dogs were administered rescue analgesia (morphine 0.5 mg/kg IM). Statistical analysis was performed using linear mixed models and Fisher's exact test (p < 0.05)., Results: Pain and sedation scores and physiological parameters were not significantly different between treatments. Three dogs in VG (25%) and none in SG (0%) required rescue analgesia (p = 0.109). Adverse effects (i.e. vomiting and melena) were observed in two dogs in SG and were thought to be related to stress and/or nonsteroidal anti-inflammatory drug toxicity., Conclusions: The administration of buprenorphine with carprofen preoperatively provided adequate postoperative analgesia for the majority of dogs undergoing OVH without serious adverse events. Prevalence of rescue analgesia was not significantly different between groups; however, it could be clinically relevant and explained by a type II error (i.e. small sample size). Future studies are necessary to determine if analgesic efficacy after Simbadol and Vetergesic is related to individual variability or pharmacokinetic differences.
- Published
- 2018
- Full Text
- View/download PDF
199. Development of a video-based teaching tool on local anesthetic techniques in small animals.
- Author
-
Steagall PV, Luna SP, Monteiro BP, and Burns P
- Subjects
- Animals, Humans, Mammals, Pain, Postoperative prevention & control, Pain, Postoperative surgery, Anesthetics, Local administration & dosage, Clinical Competence, Pain, Postoperative veterinary, Video Recording
- Abstract
Competing Interests: Use of this article is limited to a single copy for personal study. Anyone interested in obtaining reprints should contact the CVMA office (hbroughton@cvma-acmv.org) for additional copies or permission to use this material elsewhere.
- Published
- 2017
200. Agreement among undergraduate and graduate veterinary students and veterinary anesthesiologists on pain assessment in cats and dogs: A preliminary study.
- Author
-
Doodnaught GM, Benito J, Monteiro BP, Beauchamp G, Grasso SC, and Steagall PV
- Subjects
- Anesthesiologists, Animals, Education, Veterinary, Students, Cats physiology, Dogs physiology, Pain Measurement veterinary
- Abstract
This study investigated agreement among undergraduate and graduate veterinary students and veterinary anesthesiologists on video pain assessment at the University of Montreal. Pain assessment in dogs and cats appeared to be affected by gender, previous experience, and degree of training despite a small population of observers.
- Published
- 2017
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.